See the latest news and media coverage for Empower. We track all announcements, press releases, and industry mentions in real time, all in one place.
Accredited compounding pharmacy and FDA-registered outsourcing facility
empowerpharmacy.comLast updated
In short: Empower drew an FDA warning letter, a critical investigation, layoffs and multiple legal battles.
The organization anticipates availability of compounded peptides by mid-November following new enforcement discretion rules. Licensed pharmacies will provide these medications through regulated pathways and quality controls.
New 1% and 2% concentrations are now available for both the facial serum and scalp solution products.
The facility filled a critical medication shortage for emergency medical teams operating near Spokane, highlighting its urgent supply chain capabilities.
The committee recommended six of seven peptides for Category 1 inclusion, preserving regulated compounding access.
Empower Pharmacy was profiled in a recent investigation by KING 5, including a case in which a patient died while taking ...
The FDA cites copying brand-name treatments and sterile drug safety concerns in its latest directive against the Houston-based compounder.
Even after numerous FDA warnings, the agency hasn't stopped Empower Pharmacy from producing drugs at a scale rarely — if ever — seen in the...
Empower Pharmacy, a large GLP-1 compounding pharmacy that’s faced allegations of poor quality drugs and a legal challenge from Eli Lilly, has stopped operations at...
Track Empower and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.
